{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T16:10:02Z","timestamp":1748794202168,"version":"3.41.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"TOA EIYO Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jphs.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T03:31:30Z","timestamp":1456889490000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits"],"prefix":"10.1016","volume":"130","author":[{"given":"Toshiki","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2016.02.007_bib1","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","article-title":"Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013)","volume":"78","author":"Group JCSJW","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2016.02.007_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2016.02.007_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd3682","article-title":"Novel molecular targets for atrial fibrillation therapy","volume":"11","author":"Dobrev","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jphs.2016.02.007_bib4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCRESAHA.114.302362","article-title":"Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation","volume":"114","author":"Woods","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2016.02.007_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2016.02.007_bib6","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1067\/mhj.2001.109952","article-title":"Pharmacologic management of atrial fibrillation: current therapeutic strategies","volume":"141","author":"Levy","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jphs.2016.02.007_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0706493","article-title":"Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias","volume":"147","author":"Takahara","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/106002809603000612","article-title":"Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use","volume":"30","author":"Chow","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jphs.2016.02.007_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/B978-0-12-417197-8.00013-4","article-title":"Constitutive activity of the acetylcholine-activated potassium current IK,ACh in cardiomyocytes","volume":"70","author":"Voigt","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.81.4.512","article-title":"Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation","volume":"81","author":"Yue","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2016.02.007_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0008-6363(99)00178-9","article-title":"Ionic mechanisms of electrical remodeling in human atrial fibrillation","volume":"44","author":"Bosch","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jphs.2016.02.007_bib12","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1111\/j.1540-8167.2006.00401.x","article-title":"Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current","volume":"17","author":"Undrovinas","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jphs.2016.02.007_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiologic basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jphs.2016.02.007_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2016.02.007_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.112.198887","article-title":"A\u00a0novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias","volume":"344","author":"Belardinelli","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.02.007_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3565(24)39220-1","article-title":"Tertiapin potently and selectively blocks muscarinic K+ channels in rabbit cardiac myocytes","volume":"293","author":"Kitamura","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.02.007_bib17","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1161\/CIRCULATIONAHA.105.575332","article-title":"The G protein-gated potassium current IK,ACh is constitutively active in patients with chronic atrial fibrillation","volume":"112","author":"Dobrev","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2016.02.007_bib18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/CIRCULATIONAHA.105.561738","article-title":"Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias","volume":"113","author":"Cha","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2016.02.007_bib19","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/j.1476-5381.1995.tb17237.x","article-title":"SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells","volume":"116","author":"Hara","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-3565(25)21169-7","article-title":"Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells","volume":"279","author":"Watanabe","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.02.007_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1540-8167.2005.50028.x","article-title":"The mechanism of atrial antiarrhythmic action of RSD1235","volume":"16","author":"Fedida","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jphs.2016.02.007_bib22","first-page":"276","article-title":"Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs","volume":"284","author":"Beaughard","year":"1986","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jphs.2016.02.007_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1254\/jjp.87.74","article-title":"Acute electropharmacological effects of intravenously administered amiodarone assessed in the in\u00a0vivo canine model","volume":"87","author":"Sugiyama","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2013.10.054","article-title":"Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model","volume":"720","author":"Varkevisser","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.108.137729","article-title":"Antitorsadogenic effects of (\u00b1)-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits","volume":"325","author":"Wang","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.02.007_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1254\/jphs.FP0060298","article-title":"Comparison of four rate-correction algorithms for the ventricular repolarization period in assessing net effects of IKr blockers in dogs","volume":"102","author":"Takahara","year":"2006","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2016.02.007_bib27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/HJH.0b013e3282f5ed44","article-title":"G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands","volume":"26","author":"Yoro Sy","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jphs.2016.02.007_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1085\/jgp.201310996","article-title":"The G-protein-gated K+ channel, IKACh, is required for regulation of pacemaker activity and recovery of resting heart rate after sympathetic stimulation","volume":"142","author":"Mesirca","year":"2013","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jphs.2016.02.007_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cvr\/cvt006","article-title":"The new antiarrhythmic drug vernakalant: ex\u00a0vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation","volume":"98","author":"Wettwer","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jphs.2016.02.007_bib30","first-page":"253","article-title":"Effects of vernakalant on refractory period and conduction velocity are preserved after electrical remodeling","volume":"35","author":"Van Hunnik","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jphs.2016.02.007_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2008.08.018","article-title":"Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone","volume":"596","author":"Takahara","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2016.02.007_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.CIR.82.1.274","article-title":"Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues","volume":"82","author":"Wang","year":"1990","journal-title":"Circulation"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:54:41Z","timestamp":1748793281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861316000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1347861316000281"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2016.02.007","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}